Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,767 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment

NCT04557956

Conditions
Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma, +11 more
Locations
  • UM Sylvester Comprehensive Cancer Center at Aventura Aventura, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

NCT04211337

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) Los Angeles, California, United States
  • University of California Davis (UC Davis) Comprehensive Cancer Center Sacramento, California, United States
View all 143 locations
View Trial Details

Related conditions